Nicotinic receptors containing ␣7 subunits are ligand-gated ion channels widely distributed in the nervous system; they influence a diverse array of events because of their high relative calcium permeability. We show here that nicotine-induced whole-cell responses generated by such receptors can be dramatically potentiated in a rapidly reversible manner by some but not all albumins. The potentiation involves increases both in potency and efficacy with no obvious differences in rise and fall times of the response. The potentiation is not reduced by removing absorbed components; it is abolished by proteolysis, suggesting that the albumin protein backbone is essential. The fact that some albumins are ineffective indicates that minor differences in amino acid sequence may be critical. Experiments with open channel blockers indicate that the potentiation involves increased responses from active receptors rather than recruitment of receptors from a previously silent pool. Single channel recordings reveal that the potentiation correlates with increased single channel opening probability, reflected in increased frequency of channel opening and increased mean channel open time. The potentiation can be exploited to overcome blockade by noncompetitive inhibitors such as ␤-amyloid peptide. The results raise the possibility that endogenous compounds use the site to modulate receptor function in vivo, and suggest that the receptors may represent useful targets for therapeutic intervention in cases where they have been implicated in neuropathologies such as Alzheimer's disease.
ments with open channel blockers indicate that the potentiation involves increased responses from active receptors rather than recruitment of receptors from a previously silent pool. Single channel recordings reveal that the potentiation correlates with increased single channel opening probability, reflected in increased frequency of channel opening and increased mean channel open time. The potentiation can be exploited to overcome blockade by noncompetitive inhibitors such as ␤-amyloid peptide. The results raise the possibility that endogenous compounds use the site to modulate receptor function in vivo, and suggest that the receptors may represent useful targets for therapeutic intervention in cases where they have been implicated in neuropathologies such as Alzheimer's disease.
The ability to modulate the function of ionotropic receptors in situ offers a potentially powerful method for therapeutic intervention. By altering the response of a receptor to endogenous agonists, the modulator can change the level of signaling without necessarily changing the temporal or spatial pattern of the signaling. One of the most successful examples of therapeutic intervention based on this strategy is the use of benzodiazepines to enhance the response of GABA A receptors and augment inhibitory activity in the central nervous system (Macdonald and Olsen, 1994) .
Nicotinic acetylcholine receptors (nAChRs) are widely expressed in the nervous system and have been implicated in a variety of behaviors and neuropathologies. One of the most abundant is a species composed of ␣7 subunits (␣7-nAChRs) that has a high relative permeability to calcium, exceeding that of NMDA receptors. Because of this and because of their diverse locations, ␣7-nAChRs can influence a wide range of cellular functions, including enhancement of transmitter release (McGehee et al., 1995; Gray et al., 1996) , generation of synaptic currents, activation of second messenger cascades, and regulation of neurite extension, apoptosis, and neuron survival (for reviews, see Broide and Leslie, 1999; Margiotta and Pugh, 2003) . Recent evidence suggests that ␣7-nAChRs are also involved in cognitive events (Levin et al., 1999) and may be specifically blocked in Alzheimer's disease (Liu et al., 2001; Pettit et al., 2001) .
Most therapeutic strategies targeting neuronal nAChRs have made use of compounds designed to act as agonists or antagonists. Examples include compounds to treat nicotine addiction, generate nociception, and ameliorate Alzheimer's disease (for reviews, see Francis et al., 1999; Dani et al., 2001) . Modulation of receptor function may offer an alternative strategy, however, as suggested by the finding that plant alkaloids can potentiate the response of ␣4/␤2-containing nAChRs (Schrattenholz et al., 1996) . Evidence that ␣7-nAChRs may also be subject to potentiation comes from reports that the antihelmintic ivermectin (Krause et al., 1998) , the neuropeptide PACAP (Pardi and Margiotta, 1999) , and the hormone prostaglandin E 2 (Du and Role, 2001) can each increase the whole-cell response generated by the receptors.
We now report a dramatic potentiation of ␣7-nAChR re-sponses by specific albumins. The effect seems to depend on the peptide sequence of the albumin rather than on an absorbed component, and it includes both an increase in the affinity of the receptor for agonist and an increase in the maximum response the receptors generate. The potentiation is mediated by an increase in channel open time rather than recruitment of previously inactive receptors. The results suggest that it may be possible to exploit existing sites on ␣7-nAChRs to increase substantially the response they produce in vivo.
Materials and Methods
Cell Cultures. Chick cultures were prepared from embryonic day 8 (E8) ciliary ganglion neurons and maintained for 4 to 7 days as described previously (Nishi and Berg, 1981) before analysis. Freshly dissociated ciliary ganglion neurons were obtained from E13 to 14 embryos and were examined 1 to 5 h later as described previously (Liu and Berg, 1999b) . Rat hippocampal cultures were prepared by dissociating E18/19 hippocampi and maintaining the cells in culture for 8 to 18 days as described previously (Liu et al., 2001) .
Electrophysiology. All experiments were performed at room temperature (20-23°C). Both perforated-patch and conventional whole-cell patch-clamp recordings were performed as described previously (Liu and Berg, 1999b , and references therein). The composition of the bathing solution and of the pipette solutions for perforated-patch and conventional patch-clamp recordings was as described previously (Liu and Berg, 1999b) . Agonist (nicotine) with and without the indicated albumins was rapidly applied using a multibarrel rapid-exchange system that achieved fluid exchange in Յ3 ms (Zhang et al., 1994) . A relatively large recording electrode was used (1-1.5 M⍀ resistance with 80% series resistance compensation). The rapid application and low-resistance recording were required to observe the full extent of potentiation, given the rapid desensitization of the response. When compounds were to be applied for several minutes or more [e.g., albumins for several minutes, ␣-bungarotoxin (␣Bgt) for an hour], they were also added to the bath for the indicated times.
The procedures for single channel data acquisition and analysis have been described in detail previously (McNerney et al., 2000) . Briefly, E14 ciliary ganglion neurons were dissociated and bathed in a standard recording solution (RS), containing 145.0 mM NaCl, 5.3 mM KCl, 5.4 mM CaCl 2 , 0.8 mM MgSO 4 , 5.6 mM glucose, and 5.0 mM HEPES acid pH 7.4, or in RS containing 75 M bovine serum albumin (BSA) and termed RS ϩBSA . Outside-out membrane patches were excised from the neurons, held at Ϫ100 mV, and exposed to 0.5 M nicotine dissolved in RS or RS ϩBSA by gentle pressure microperfusion (2-5 psi). The resulting currents were digitized at 50 kHz and filtered to a final cutoff frequency (f c ) of 6.8 kHz (Ϫ3 dB), allowing resolution of channel openings with durations Ͼ98 s [2 times the filter rise time (t r ϭ 0.3321/f c ); Colquhoun and Sigworth, 1995] . Single nAChR channel events were detected by visual inspection of transitions from the baseline current and manually selected such that only those events exceeding preset thresholds for amplitude (2 times noise) and duration (98 s) were subsequently analyzed. For each recording, single channel currents were first compiled into amplitude histograms (0.2-pA bins) and fit to multiple Gaussian functions using a Simplex least-squares algorithm that minimizes the difference between actual and fit values (pSTAT; Axon Instruments, Foster City, CA). The sum of four Gaussian functions best fit the amplitude distributions, as determined by eye, and in seven cases, by comparing F statistic values obtained from fits conducted with four versus five or three functions. In each of these cases, the fits using four Gaussian components were significantly improved over those using three components (p Ͻ 0.005) and not significantly different from those using five components (p Ͼ 0.1). Because the individual functions overlapped somewhat, the range of each current class was determined by calculating the critical amplitudes (A c ) between peaks in the distribution that minimized misclassified events from adjacent ranges, as described previously (Colquhoun and Sigworth, 1995) .
To analyze BSA effects on nAChRs, the single channel conductance, steady-state open probability, open frequency, and open duration were compared for each current class, x. Single channel conductances (␥ x ) were determined using reversal potential values determined previously from patches where full current-voltage plots were obtained (McNerney et al., 2000) . The steady-state opening probability for each class (P open,x ) was assessed using %P open,x ϭ 100[⌺ t,x /(TL x )], where ⌺ t,x was obtained from the summed open durations of channel class x. T represents the total record time (ca. 40 s in all cases), and L x represents the number of channels of that current class in the patch. L x was estimated from the number of x value current levels visualized in a record and was usually 1 or 2. This method provides an upper limit estimate of %P open,x because L x is likely to be an underestimate of the actual number of channels in the patch (Colquhoun and Hawkes, 1995 (Sigworth and Sine, 1987; Colquhoun and Sigworth, 1995) and fitted by maximum likelihood methods using Intrv5 [Interval Analysis 3.12 (1994) Biochemical Procedures. BSA was extracted with the organic solvents chloroform, methanol, or acetonitrile. BSA (1 g) was suspended in 50 ml of solvent, shaken vigorously for 2 h, centrifuged to collect the precipitate, and dried by a stream of nitrogen. The BSA was then resuspended in recording solution and tested. Dialysis of denatured BSA was done by dissolving BSA in 8 M urea to yield 10 mg/ml, adjusting the pH to 8.0 with sodium hydroxide, and then adding iodoacetic acid to a final concentration of 20 mM and incubating the solution at room temperature for 30 min to alkylate-free sulfhydryls. The BSA solution was then dialyzed against 500 ml of 8 M urea for 15 h followed by dialysis against 4 ϫ 2 liters of recording solution for 24 h and then tested for activity. BSA at 10 mg/ml in recording solution was also treated with 10 mM dithiothreitol for 30 min at room temperature, alkylated with 20 mM iodoacetic acid, dialyzed for 2 h against recording solution, and then tested.
Protease treatments of BSA were conducted by reducing and alkylating BSA disulfides with dithiothreitol and iodoacetic acid as described above, and then incubating with 0.25 ml of ␣-chymotrypsin-agarose or N-tosyl-L-phenylalanine chloromethyl ketone-trypsinagarose for 15 h at 37°C with shaking. The proteases were removed by centrifugation, and the BSA solutions were diluted with recording solution and tested. Reduction and alkylation were required to fully inactivate the BSA activity by the proteases. Pepsin digestion of BSA was conducted by dissolving BSA in 1% acetic acid to yield 10 mg/ml, adding 0.2 ml of pepsin-agarose, incubating 15 h at 37°C with shaking, removing the pepsin-agarose by centrifugation, lyophilizing the peptide solution, and resuspending in recording solution for testing.
Controls for the pepsin digestion included either omission of the pepsin-agarose or conducting the experiment as described but adjusting the pH of the BSA solution to 7.0 before adding the pepsinagarose.
Limited pepsin digestion of BSA and purification of peptide fragments were conducted as described previously (Feldhoff and Peters, 1975) . The carboxyl terminal (amino acids 308-583) and amino terminal (amino acids 1-307) halves of BSA obtained from a 20-min pepsin digestion in the presence of octanoic acid were purified by a combination of ion exchange and size exclusion chromatography. Additional smaller peptides were purified by size-exclusion and reverse-phase chromatography. These included peptides corresponding to amino acids 308 to 386 and 506 to 583. Peptide identities were confirmed by mass determinations by electrospray ionization mass spectrometry.
Materials. White Leghorn chick embryos were obtained locally and maintained at 37°C in a humidified incubator. ␣Bgt was purchased from Biotoxins (St. Cloud, FL). ␤-Amyloid peptide 1-42 (A␤) was obtained from Calbiochem (La Jolla, CA) and prepared as described previously (Liu et al., 2001) . N-tosyl-L-phenylalanine chloromethyl ketone-trypsin-agarose and pepsin agarose were purchased from Pierce Chemical (Rockford, IL). All other drugs, including ivermectin, BSA, other albumins, and ␣-chymotrypsin-agarose were purchased from Sigma-Aldrich (St. Louis, MO). GenBank accession numbers for albumin sequences analyzed were as follows: bovine, ABBOS; horse, ABHOS; sheep, ABSHS; dog, CAA76841; rabbit, P49065; cat, JC4660; pig, P08835; human, ABHUS; rat, P02770; mouse, CAA09617; and chicken, ABCHS.
Results

BSA-Mediated Enhancement of ␣7-nAChR
Responses. Typically ␣7-nAChRs produce rapidly activating and rapidly desensitizing currents (Zorumski et al., 1992; Alkondon and Albuquerque, 1993; Zhang et al., 1994) , although some variants can produce a slowly desensitizing response (Cuevas and Berg, 1998; Yu and Role, 1998) . Diagnostically, ␣7-nAChR responses can be blocked by nanomolar concentrations of either ␣Bgt (Couturier et al., 1990) or methyllycaconitine (Alkondon et al., 1992) .
Chick ciliary ganglion neurons in cell culture express substantial numbers of ␣7-nAChRs as measured with 125 I-␣Bgt binding and exhibit spontaneous excitatory synaptic potentials generated in part by ␣7-nAChR activation (Chen et al., 2001 ). Whole-cell patch-clamp recording from E8 ciliary ganglion neurons grown 1 week in culture, however, failed to detect significant nicotine-induced responses that could be attributed to ␣7-nAChRs (Fig. 1A) . Unexpectedly, the inclusion of BSA in the perfusion solution allowed a large, rapidly activating and rapidly desensitizing nicotinic response to be seen. The response was not seen after treatment with ␣Bgt ( Fig. 1B) , indicating that it was generated by ␣7-nAChRs (Fig. 1C) .
In contrast to ciliary ganglion neurons maintained in culture, freshly dissociated E13 neurons display a substantial ␣7-nAChR response when challenged with nicotine. Nonetheless, BSA had an enormously potentiating effect on the response. The effect was so great that the ␣7-nAChR currents could not be accurately measured when recorded in neurons voltage-clamped at Ϫ60 mV. At a holding potential of Ϫ20 mV, 75 M BSA increased the peak nicotine-induced whole-cell current by an order of magnitude ( Fig. 2A) , and the increased response was blocked by ␣Bgt as expected for ␣7-nAChRs (data not shown). The temporal profile of the response, including both rise and fall times, were similar to those of ␣7-nAChRs in untreated cells. Thus, at Ϫ20 mV, rise times (10-90% of peak) for control and BSA-treated neurons were 4.8 Ϯ 0.3 and 5.4 Ϯ 0.4 ms, respectively, whereas decay time constants for the large, rapidly decaying component of the response were 21.3 Ϯ 2.8 and 15.4 Ϯ 1.4 ms, respectively (mean Ϯ S.E.M.; n ϭ 10). The similarity in decay time suggests that the BSA-mediated potentiation of the ␣7-nAChR response is unlikely to result from a dramatic reduction in the rate of receptor desensitization.
Generating a dose-response curve for BSA potentiation of the ␣7-nAChR response indicated an EC 50 value of about 10 M (Fig. 2B ). The BSA effect was completely reversible: less than 20 s was required for maximal potentiation and less than 20 s for return to control levels (Fig. 3, A and B) . Reapplication of BSA reproduced the potentiation (data not shown). The potentiation seemed to include both an effect on agonist affinity and an effect on the maximal whole-cell response. Thus, in the presence of BSA, the dose-response curve for nicotine was shifted slightly to lower agonist concentrations but also reached significantly greater maximum values (Fig. 4) . Interpreting changes in the dose-response curve for ␣7-nAChRs, however, is complicated by the fact that it is influenced by receptor desensitization, which can limit response amplitude and varies with agonist concentration (Zhang et al., 1994) .
Specificity of the Potentiation. The potentiation preferentially affected ␣7-nAChRs and was produced by albumins obtained from several, but not all, species. Little potentiation was seen in either the non-␣7 nicotinic response or the GABA A response in E13 ciliary ganglion neurons treated with BSA (Fig. 5A ). BSA had no significant effect on either the AMPA-or NMDA-induced responses from rat hippocampal neurons, although it did potentiate ␣7-nAChR responses from the neurons as it did in chick ciliary ganglion neurons (Fig. 5B) . Over half of the albumins tested on chick neurons produced substantial potentiation, whereas four, including chick and rat albumin, had no effect (Fig. 5C ). Rat albumin also failed to potentiate significantly the rat hippocampal ␣7-nAChR response: peak values induced by 1 mM ACh in the presence of 10 M rat albumin were 1.3 Ϯ 0.2-fold that of control responses (mean Ϯ S.E.M.; n ϭ 8 cells). The results suggest that "competent" albumins either share a critical amino acid sequence or have an absorbed component necessary to produce the potentiation.
Mechanism of the Potentiation. It is known that albumins can act as scavengers to absorb lipids and other components from blood (Peters, 1985) . One family of candidates is ivermectin-like components that might have been present in the feed of some but not all animal species supplying the albumins; ivermectin has been reported to produce significant potentiation of heterologously expressed ␣7-nAChRs (Krause et al., 1998) . Treating E13 ciliary ganglion neurons with 10 to 30 M ivermectin for 2 to 5 min, however, had no effect on the peak ␣7-nAChR response (data not shown). Moreover, extracting BSA with a variety of organic solvents, including chloroform, methanol, and acetonitrile, to remove absorbed components, had no effect on the ability of the BSA to potentiate ␣7-nAChR responses (Fig. 6A) . Nor was the potentiation diminished when the BSA was partially denatured with either urea or dithiothreitol in the presence of iodoacetamide and then dialyzed to remove absorbed components (Fig. 6A) . In contrast, extensive proteolysis to destroy the BSA protein backbone eliminated the potentiation. Pepsin, chymotrypsin, and trypsin each reduced the potentiating ability of BSA to background levels, whereas negative controls, e.g., pepsin incubation at a nonpermissive pH, had no effect (Fig. 6B) . The results are most consistent with the BSA itself generating the potentiation, and using specific domains of the protein not common to albumins from all species.
Limited proteolytic cleavage of the BSA using pepsin as described previously (Feldhoff and Peters, 1975 ) yielded a 30-kDa carboxy terminal half of the protein that remained competent. The fragment was isolated by using a combination of size exclusion and ion exchange chromatography. At 10 M, the fragment produced 560 Ϯ 80% (mean Ϯ S.E.M.; n ϭ 9) potentiation of the peak nicotine-induced response. This was indistinguishable from potentiation by intact BSA (p Ͼ 0.5). Further proteolysis, followed by high-performance liquid chromatography fractionation to separate individual fragments, failed to identify active components. Either the proteases used (pepsin or trypsin) destroyed the active site, or protein conformation, rather than sequence alone, was important for the potentiation.
The BSA-mediated potentiation was not voltage-dependent. The ratio of peak nicotine-induced responses obtained at ϩ40 mV to those seen at Ϫ20 mV in the same neurons under control conditions was 9.2 Ϯ 1.2% (n ϭ 5). The ratio seen in the presence of 10 M BSA was identical: 9.2 Ϯ 1.3% (n ϭ 6).
The BSA effect was not mediated via common second messenger pathways such as those depending on intracellular calcium or G protein-coupled receptors. Dialyzing the interior of the neuron from the patch pipette either with BAPTA to chelate calcium or with a stable GDP analog had no effect on the BSA-induced potentiation (Fig. 7) . Neither did the compounds nor a stable GTP analog have any effect on control responses in the absence of BSA. Blockers of protein kinases A, C, and G also seemed to be without effect on the Fig. 5 . Receptor type and albumin specificity. A, effects of 10 M BSA on E13 chick ciliary ganglion ␣7-nAChR, non-␣7 nAChR, and GABA A receptor responses were assessed by measuring the whole-cell response either to 20 M nicotine, or to nicotine after treatment with 100 nM ␣Bgt, or to 20 M GABA, respectively, and normalizing the results to control responses from the same neurons before BSA application. Individual neurons were tested for a single kind of receptor response Ϯ BSA. B, effects of 10 M BSA on the AMPA, NMDA, and ␣7-nAChR responses of rat hippocampal neurons in cell culture, elicited with 100 M AMPA, 100 M NMDA (ϩ 1 M glycine in the absence of Mg 2ϩ ), and 1 mM acetylcholine (in the presence of 0.5 M atropine), respectively, and analyzed as in A for ciliary ganglion neurons. BSA significantly potentiated both ciliary ganglion and hippocampal ␣7-nAChR responses while having only a small effect on ciliary ganglion non-␣7 nAChR and GABA A receptor responses, and no significant effect on hippocampal AMPA or NMDA receptor responses. C, mean peak nicotine-induced response of E13 ciliary ganglion neurons was measured after treatment with 10 M albumin from the indicated species, and the results were normalized to control responses from the same neurons. Seven albumins significantly potentiated the response, whereas four did not. Values represent the mean Ϯ S.E.M. from 10 to 16 neurons per condition. A, aliquots of BSA were extracted with the organic solvents methanol, chloroform, or acetonitrile (ACN), or reversibly denatured by dialysis against urea and iodoacetamide (urea/IAA), or reduced by treatment with DTT and then IAA (DTT/IAA) before dialysis into perfusion buffer and application to E13 ciliary ganglion neurons for testing. B, aliquots of BSA were proteolyzed with pepsin, chymotrypsin, or trypsin, and then, after enzyme removal or inactivation either by inhibitor or by pH adjustment, the samples were dialyzed or lyophilized and resuspended as described under Materials and Methods and tested. (Pepsin is inactive at pH 7.) Values have been normalized to control responses and represent the mean Ϯ S.E.M. for 6 to 14 neurons for each condition. Only protease treatment abolished the capacity of BSA to potentiate nicotine-induced peak responses.
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at ASPET Journals on August 15, 2017 molpharm.aspetjournals.org potentiation (Fig. 7) . The results suggest a direct interaction between albumin and ␣7-nAChRs or possibly one mediated by surface components on the neurons; intracellular signaling cascades are not likely to be required.
Properties of ␣7-nAChRs Affected by the Potentiation. It has been suggested that only a small fraction of the ␣7-nAChRs present on chick ciliary ganglion neurons may be functionally available (McNerney et al., 2000) . This assessment may require revision because it relied on ␣Bgt binding to quantify ␣7-nAChRs; the stoichiometry of ␣Bgt binding may be greater than previously thought, if the results obtained with soluble acetylcholine binding protein (Brejc et al., 2001) can be extended to ␣7-nAChRs. Nonetheless, it was important to consider the possibility that the potentiation of the whole-cell ␣7-nAChR response by BSA represented a recruitment of receptors from a previously "silent" pool to a pool that was now functionally available for nicotine-induced activation. This was tested by using an open channel blocker. We reasoned that if the potentiation represented silent receptors being recruited de novo by the BSA treatment, then previous exposure to agonist in the presence of an open channel blocker (while the receptors were in silent mode) would have no effect on the ability of BSA subsequently to produce a large nicotine-induced response. The protocol would require removing agonist and unbound open channel blocker before adding the BSA so that no blockade of newly recruited receptors would occur. Alternatively, if the open channel blocker was able to attenuate the BSA effect as it did control responses even though the blocker was only available before the BSA incubation, the results would suggest that the same receptor population produced both the control and potentiated whole-cell responses.
Chlorisondamine has been commonly used as an open channel blocker of nAChRs (Amador and Dani, 1995; Hicks et al., 2000) . At 20 M chlorisondamine quickly produced a dramatic reduction in the peak whole-cell nicotinic response (Fig. 8A) , which is dominated by ␣7-nAChRs (Liu and Berg, 1999b) . It also almost completely eliminated the slower non-␣7 nAChR response. Agonist was applied for 1 s at 30-s intervals to allow full recovery from receptor desensitization between trials, and perforated patch-clamp recording was used to minimize rundown of the response during the experiment (Liu and Berg, 1999a) . After even a few applications of agonist, the chlorisondamine reduced control responses by about 80% (Fig. 8B) . The reduction was consistent with an open channel blockade because it did not occur if the chlorisondamine was applied continuously during the 29-s intervals between nicotine applications but excluded during the 1-s nicotine applications themselves (Fig. 8B) . After inducing open channel blockade with chlorisondamine, we removed unbound material and tested the nicotinic response subsequently in the presence of BSA. At 10 M BSA potentiated the residual response about 3-fold (Fig. 8B) . At 75 M it produced a 6-fold potentiation (Fig. 8B) . Similar results were obtained when the experiment was performed with 100 M nicotine as agonist rather than the usual 20 M (5.1 Ϯ 0.5-fold potentiation by 75 M BSA; n ϭ 5 neurons). The results are entirely consistent with the potentiation being exerted on the residual response, according to the doseresponse curve of BSA (Fig. 2) . Had the potentiation represented BSA recruitment of a previously inactive population that was not affected by the chlorisondamine treatment, the response in the presence of 10 M BSA, for example, should have been 30-fold greater than the residual response, rather than the 3-fold observed. This was clearly not the case.
Because BSA did not seem to increase the number of functional ␣7-nAChRs, we conducted recordings from excised outside-out neuron patches to determine which functional single channel properties might be altered to account for the potentiation. Previous studies on chick ciliary ganglion neurons identified single nAChR channel events of 25, 40, 60, and 80 pS activated by 0.5 M nicotine in excised outside-out neuron patches (Margiotta and Gurantz, 1989; McNerney et al., 2000) . The 60-and 80-pS events were brief (Ͻ0.2 ms) and were blocked by ␣Bgt, indicating that they probably resulted from activation of ␣7-nAChRs. The 25-and 40-pS events were of longer duration and not blocked by ␣Bgt, suggesting they were produced by the non-␣7 nAChRs on the neurons. Recent studies have further distinguished brief 25-and 40-pS events (Ͻ0.2 ms) that can be blocked by ␣Bgt, marking them as additional candidates for ␣7-nAChR responses (J. F. Margiotta and Q. Nai, unpublished observations). BSA did not detectably change the amplitudes of the single channel events induced by 0.5 M nicotine (Fig. 9, A and B) , indicating no change in single channel conductance. In contrast, BSA treatment significantly increased the steady-state opening probability (%P open ) of both the 60-and 80-pS events with about 5-fold increases evident for both after a 10-min exposure to 75 M BSA ( Fig. 9C; (Fig. 9D) . The increase in T open seems to result from a larger fraction of longer duration openings in patches from BSA-treated neurons, as shown for the 60-pS class of events (Fig. 9, E and F) . Similar results were obtained for the 80-pS events (data not shown). No single channel events were seen during comparable recording times in the absence of nicotine.
The ability of BSA to increase %P open was specific for ␣Bgt-sensitive events in the sense that the treatment had no significant effect on the long duration 25-and 40-pS events attributable to non-␣7 nAChRs in the same patches (Fig. 9C) . The fact that BSA also had no significant effect, however, on the short duration, ␣Bgt-sensitive 25-and 40-pS events (Fig.  9C) , suggests that these latter events may be produced by a distinct subclass of ␣7-nAChRs or a different class of ␣Bgt-sensitive receptors. About 5% of the ␣Bgt binding sites in ciliary ganglia are associated with receptors lacking any known gene product (Pugh et al., 1995) ; their cellular source and functional responses remain unknown, but they may contribute to some of the single channel events observed.
Overall, the single channel results are consistent with the whole-cell recordings presented above, and suggest that the BSA-dependent potentiation of ␣7-nAChR responses is caused by increases in %P open , F open , and T open for two prominent classes of channel events.
BSA-Mediated Compensation for Inhibition of ␣7-nAChRs by A␤. A␤ specifically and potently inhibits ␣7-nAChR function by a noncompetitive mechanism, suggesting the possibility that the receptors represent an important early molecular victim of Alzheimer's disease (Liu et al., 2001; Pettit et al., 2001) . The ability to potentiate ␣7-nAChR function could provide a mechanism for partially overcoming such inhibition and helping to alleviate symptoms of the disease involving the receptors. We evaluated this by examining the inhibition of ␣7-nAChRs by A␤ in the presence and absence of BSA. A␤ at 100 nM produced a substantial inhibition of the whole-cell ␣7-nAChR response in E13 ciliary ganglion neurons as reported previously. Coapplication of BSA at a concentration near the EC 50 value for potentiation returned the response amplitude to near control levels even in the continued presence of A␤ (Fig. 10) . A higher concentration of 75 M BSA produced a much larger response (Fig.  10) , consistent with the concentration dependence of the BSA effect on control responses (Fig. 2) . Thus, BSA-mediated potentiation can, in effect, compensate for inhibition by A␤ even though the latter was previously shown to be noncompetitive with respect to agonist (Liu et al., 2001) .
Discussion
The results demonstrate that native ␣7-nAChRs can be significantly potentiated, and that the potentiation can produce up to an order of magnitude increase in the whole-cell response. The potentiation includes an increase in agonist affinity and an increase in the maximum amplitude of the response. The mechanistic basis for the potentiation seems to be an increase in the steady-state channel opening probability produced both by an increased frequency of channel opening and an increased mean channel open time. No change is seen in single current amplitude, and no evidence suggests the potentiation depends on the recruitment of a previously silent pool of receptors. No change is seen in the temporal profile of the whole-cell response that could account for the potentiation.
The ability of certain albumins to produce the potentiation seems to depend on information contained in the protein backbone rather than on absorbed components. Neither extensive extraction with organic solvents nor unfolding followed by exhaustive dialysis diminished the ability of BSA to induce the potentiation. Proteolysis, on the other hand, completely abolished it. The finding that the carboxyl half of BSA was sufficient to produce the potentiation focused attention on the amino acid sequences therein. A comparison of the active albumins with those of the inactive ones indicated six distinct sites at which the two groups diverged by at least one amino acid. Examining the three-dimensional X-ray crystallographic structure of human serum albumin indicated that five of the six sites were likely to reside on the surface of the protein where they could interact with other molecules (Curry et al., 1998) . One or more of these, possibly in a conformation-dependent manner, may be responsible for causing the potentiation of ␣7-nAChR responses. The properties of the potentiation are consistent with the albumins acting as allosteric modulators of the ␣7-nAChR. The modulation may result from a direct interaction between the albumin and the receptor. This is suggested by the finding that the potentiation was rapid, reversible, and reproducible, and did not depend on any of a variety of common second messenger systems. Moreover, the albumin was effective at sustaining the potentiation when applied to excised outsideout patches. We cannot exclude the possibility, however, that the effect is indirect, e.g., that the albumin reversibly binds a negative modulator tethered in the vicinity of the receptor. The potentiation was most pronounced for ␣7-nAChRs, although a small potentiation could be seen for certain other ionotropic receptors.
A previous study examined albumin effects on nicotinic receptors and concluded that non-␣7 nAChR responses were potentiated in ciliary ganglion neurons (Gurantz et al., 1993) . The techniques used then would not have revealed the rapidly decaying ␣7-nAChR responses normally displayed by the neurons. The present results find little, if any, albumin effect on ciliary ganglion non-␣7 nAChRs and suggest instead that the potentiated response seen previously actually arose from enhanced ␣7-nAChR currents persisting sufficiently long as to override the much smaller non-␣7 responses. This possibility was not tested at the time because ␣7-nAChRs had not yet been shown to represent functional ligand-gated ion channels. In other respects the present results are consistent with the previous study, including the lack of changes seen in non-␣7 nAChR single channel properties, the small enhancement of GABA A receptor responses by BSA, and the fact that some albumins are effective, whereas others are not. An additional point worth comment was a finding in the previous study that cAMP produced a small enhancement of the whole-cell nicotinic response and that the enhancement was nonadditive with that produced by BSA (Gurantz et al., 1993) . We found no requirement for second messengers in the potentiation of ␣7-nAChR responses by BSA, although a cAMP-dependent process can increase to some extent the ␣7-nAChR response (Pardi and Margiotta, 1999) . The simplest explanation is that the BSA effect on ␣7-nAChRs is independent from cAMP pathways and either obscures their effects in this case or converges on a common target.
Three components that increase ␣7-nAChR responses have been reported previously. Ivermectin was found to produce a large enhancement of the nicotinic responses generated by heterologously expressed ␣7-nAChRs if supplied in advance of agonist (Krause et al., 1998) . No effect of ivermectin was seen in the present experiments, however, with native ␣7-nAChRs on chick ciliary ganglion neurons. Either the source of ivermectin and associated minor components is critical for the effect, or the source of ␣7-nAChRs determines the outcome. Another known modulator of ␣7-nAChRs is prostaglandin E 2 , which increases the opening probability and open duration of 23-pS single channel events attributed to the receptors on chick sympathetic neurons (Du and Role, 2001 ). Whole-cell currents generated by such receptors have relatively slow kinetics of activation and desensitization, different from the ␣7-nAChRs described here. The prostaglandin E 2 effect was thought to be indirect, possibly relying on calcium as a second messenger (Du and Role, 2001) . A third modulator is PACAP, a neuropeptide endogenous in the ciliary ganglion. PACAP acts through adenylate cyclase and protein kinase A to enhance the responses of both ␣7-and non-␣7 nAChRs on the neurons (Pardi and Margiotta, 1999) . Neither prostaglandin E 2 nor PACAP, however, produced the dramatic potentiation of ␣7-nAChR responses seen here with BSA.
The significance of the present findings is 3-fold. First, they indicate that the response of ␣7-nAChRs can be dramatically potentiated by increasing the steady-state opening probability of the receptors. The previously reported low %P open values associated with both the 60-and 80-pS channel events of ciliary ganglion ␣7-nAChRs (McNerney et al., 2000) are not, therefore, inherently rigid features of the receptors but rather are subject to allosteric modulation. The site of interaction and the mechanism accounting for the potentiation will be subjects of considerable interest for future analysis.
The second important aspect of the findings is the recognition that a site exists on native ␣7-nAChRs capable of dramatic modulation. This finding raises the possibility that endogenous compounds, possibly neuropeptides but conceivably compounds of completely different composition, exploit the site in vivo during normal physiological function. Blood levels of albumin are typically about 40 mg/ml but can be (Curry et al., 1998 ). Although even this reduced level could have some effect, we think albumins are not likely to be the normal ligand acting at such sites. One reason for thinking so is that the cognate albumin (e.g., chicken albumin and chick ␣7-nAChRs) was ineffective. Identification of endogenous compounds exerting the modulation and elucidation of the physiological significance could have profound implications for nicotinic signaling in the nervous system.
One candidate modulator is lynx1, an endogenous prototoxin that has recently been shown to complex with ␣7-nAChRs when coexpressed in transfected cells (Ibanez-Tallon et al., 2002) . Lynx1 has multiple effects on the response of ␣4␤2-nAChRs, increasing the proportion of large current events but also increasing the EC 50 value for agonist and the rate and extent of receptor desensitization (Ibanez-Tallon et al., 2002) . The overall effect of lynx1 on ␣4␤2-nAChRs is very different from the dramatic potentiation of ␣7-nAChRs seen here with select albumins. How lynx1 or related family members might affect ␣7-nAChR function is not yet known.
Last, the demonstration that ␣7-nAChR function can be potentiated in a way that compensates for receptor blockade by the A␤ peptide, encourages speculation that the receptor may be a useful target for therapeutic strategies aiming at augmenting nicotinic signaling. The hope would be that knowledge about the modulatory site would permit the design of nonpeptide molecules capable of accessing and modulating the receptors in situ. This could be germane to neuropathologies such as Alzheimer's disease (Liu et al., 2001; Pettit et al., 2001 ) and neurodisorders such as schizophrenia (Leonard et al., 2000) .
